@article{JLPM11274,
author = {Kohki Okada and Kazuhiko Kotani},
title = {The integrative evaluation of pathophysiological and clinical relevance of biomarkers in inflammatory bowel disease: a narrative review},
journal = {Journal of Laboratory and Precision Medicine},
volume = {11},
number = {0},
year = {2026},
keywords = {},
abstract = {Inflammatory bowel disease (IBD), which comprises ulcerative colitis and Crohn’s disease, is a chronic relapsing inflammatory disorder driven by genetic, immune, microbial, and environmental factors. Disease monitoring still relies on invasive endoscopy and non-specific systemic markers, including C-reactive protein and erythrocyte sedimentation rate. This review evaluates emerging non-invasive biomarkers for IBD and summarizes their pathophysiological relevance, analytical characteristics, and clinical utility for assessing intestinal inflammation.},
issn = {2519-9005}, url = {https://jlpm.amegroups.org/article/view/11274}
}